...cserhan@bwh.harvard.edu CONTACT: Vikas P. Sukhatme, Emory University, Atlanta, Ga. email: vsukhatme@emory.edu Claire Quang Acular LS (acuvail 0.45%, ketorolac tromethamine) Emory...

...compared to those receiving placebo (47 mg and 56 mg, respectively)." Egalet Corp. (NASDAQ:EGLT) Sprix ketorolac tromethamine...
...level “The clinical relevance of this is reflected in the finding that patients treated with SPRIX...

...1.5% royalty payment on net sales of Egalet’s marketed pain drugs, Oxaydo oxycodone and Sprix ketorolac tromethamine. WIR...

...Egalet purchased Sprix ketorolac tromethamine nasal spray from Daiichi Sankyo’s Luitpold Pharmaceuticals Inc. subsidiary for $7 million...
...require analgesia at the opioid level. Luitpold will begin promotion of the product this quarter. Sprix...

...Pharmaceuticals Inc. company said a group of academic researchers began the AMPED registry to evaluate Sprix...
...without oral narcotics, or oral narcotics alone in patients seeking emergency medical care for pain. Sprix...
...Luitpold in 2010. Daiichi Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568), Tokyo, Japan Product: Sprix ketorolac tromethamine ( ROX-888...

...Luitpold's Regency Therapeutics division and Daiichi Sankyo launched Sprix ketorolac tromethamine nasal spray in the U.S. to...
...The wholesale acquisition price is $137.50 per box of five 126 mg single-day spray bottles. Sprix...

...FDA approved an NDA from Roxro for Sprix ketorolac tromethamine nasal spray for short-term management of acute...
...commercialization partner for the analgesic. Roxro Pharma Inc. , Menlo Park, Calif. Product: Sprix ( ROX-888...

...FDA approved an NDA from Roxro Pharma Inc. (Menlo Park, Calif.) for Sprix ketorolac tromethamine nasal spray...

...Allergan said FDA approved an NDA for Acuvail ketorolac tromethamine ophthalmic solution to treat pain and inflammation...
...a non-steroidal anti-inflammatory drug (NSAID), in September. Allergan Inc. (NYSE:AGN), Irvine, Calif. Product: Acuvail 0.45% ketorolac tromethamine...

...Roxro said FDA accepted for filing an NDA for ROX-888 for the management of acute moderate-to-severe...
...launch, which is expected by year end. Roxro Pharma Inc. , Menlo Park, Calif. Product: ROX-888...